Investors
 

NASDAQ: TTPH

$ 17.97

0.94 (5.52%)

Day High: 18.21
Day Low:  16.91
Volume:    823,800

4:00 PM ET
Sep 17, 2014



Delayed at least 20 min., by eSignal.


Stock price graph

     

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Tetraphase Pharmaceuticals's financial performance into perspective.

View all »   RSSRecent Releases

Sep 2, 2014
Tetraphase Pharmaceuticals Announces Positive Oral Dosing Data from Lead-in of IGNITE 2 Phase 3 Trial of Eravacycline in cUTI Support Advancement to Pivotal Portion

Aug 27, 2014
Tetraphase Pharmaceuticals to Participate in Upcoming Investor Conferences